Neil Averitt commentary: CVS-Aetna deal has many good features, but what of the PBMs?

(January 19, 2018) -- Much good can be said about the planned merger of CVS and Aetna, but there is also a potentially troublesome sleeper issue involving pharmacy benefit management services, which should be looked at as part of any antitrust investigation....

Related Sections